Supratek Pharma, Inc. develops drugs and related oncology therapeutic products. It offers injectable chemotherapeutic that enhances or enables an approved anticancer drug. The firm’s products include SP1014C - a novel cabazitaxel against drug resistant prostate cancer, SP1030C - novel bendamustine against chronic lymphocytic leukemia and non-Hodgkin’s lymphoma and SP1049C - a novel injectable anthracycline platform drug against chemoresistant cancers. The company was founded by Valery Alakhov in 1994 and is headquartered in Pointe-Claire, Canada.

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.

Tianjin Huada Medical Laboratory Co., Ltd., established on 2014-10-09, Business scope includes licensed projects:medical service;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).General project:Medical Research and Experimental Development;Import and export;Technology Import and Export;Import and export agency;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Experimental analysis instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Retailing of computer software, hardware and auxiliary equipment;Sales of Class II Medical Devices;housing lease;Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

BGI Biotechnology (Wuhan) Co., Ltd., established on 2013-10-31, Business scope includes biotechnology products,medical instruments,Research and development of laboratory equipment;First,two,Production, wholesale and retail of Class III medical devices;Consumables for biological research,Reagent,Wholesale and retail of instruments;biotechnology research,technical consulting,technology transfer,Technical Services;Import and export,Technology Import and Export(Goods and technologies prohibited by the state from import and export are not included);production class;6840In vitro diagnostic reagents,6840Clinical laboratory analysis equipment production category II:6870Three categories of medical software production:6840In vitro diagnostic reagents.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhenyue Biotechnology Jiangsu Co., Ltd., established on 2015-12-16, Business scope includes biotechnology development,Technical Services,technology transfer,technical consulting,software development,data processing(without foundation,added value,Telecommunications business),Sales of computer software, hardware and auxiliary equipment,Chemical Products(Free of Hazardous Chemicals),Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export),R&D of medical devices,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company was founded on April 20, 2018 and is headquartered in Seoul, South Korea.

Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test.

Genecast offers DNA testing of tumors and gene-based medicine guidance. The company claims expertise in lung, colon, liver and breast cancers. Genecast plans to use the proceeds for further research and clinical trials, as well as expanding distribution channels.

Beijing Geneplus Technology Co., Ltd. engages in the provision of tumor gene detection services. It provides medication, monitoring, postoperative recurrence monitoring, risk prediction, and early detection services. Its products include tumor precise drug gene detection for lung cancer, breast cancer, gastrointestinal tumors, and whole cancer species; as well as genetic tumor gene detection for hereditary breast and ovarian cancer, hereditary gastrointestinal cancer, and hereditary tumor. The company was founded by Xin Yi and Ling Yang on April 23, 2015 and is headquartered in Beijing, China.

Major Translational Medicine Research (Suzhou) Co., Ltd., established on 2013-03-06, The scope of business includes engaging in biomedical,Technology research and development in the field of medicine and diagnostics,Technical Services,technology transfer,technical consulting;Translational Medicine Research Services,Laboratory Testing Services,Clinical Testing Services;Biological reagents and consumables,Class I,Class II,Research and development of Class III medical devices,production and sales(The above does not contain human stem cells,Development and application of genetic diagnosis and treatment technology);Engaged in the import and export business of the above technologies and products and related supporting services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

US Agriculture LLC provides investment services. It operates and manage farmland assets and portfolios, develop and implement farmland investment strategies, underwrite and acquire farmland assets across a variety of regions and crop types, develop and implement efficient and effective reporting processes, design and implement investment policies, develop and implement asset allocation strategies, create and implement tools for market and asset targeting, and create and implement portfolio optimization tools and processes. The company was founded in 2015 and is headquartered in Indianapolis, IN.

Telo Genomics Corp. is a biotechnology company, which engages in the development and commercialization of technological products designed to personalize treatment plans for patients who have specific conditions. The firm also focuses on developing a telomere analysis platform with diagnostic and prognostic applications based on the quantification of genomic instability as a disease predictor. The company was founded by Sabine Mai on May 25, 2011 and is headquartered in Toronto, Canada.

Tsingtao Brewery Co., Ltd. engages in the manufacture and sale of beer and related products. It operates through the following business segments: Shandong; South China; North China; East China; Southeast; Hong Kong, Macau, and overseas; and Finance. The Shandong segment engages in the production and sale of beer in Shandong and surrounding areas. The South China, North China, East China, and Southeast segments engage in the production and sale of beer in the respective areas. The Hong Kong, Macau, and overseas segment engages in the sale of beer in Hong Kong, Macau, and overseas. The Finance segment handles the financial management and financial transactions such as payment and collection of member units. The company offer the verities of beer include Great ocean beer, Huiquan beer, Tsingtao draft beer, Tsingtao dark beer, Tsingtao beer premium and Tsingtao beer. Tsingtao Brewery was founded in August 1903 and is headquartered in Qingdao, China.

Alliance for Sustainable Energy LLC is an American private company located in Golden, CO. The firm operates as a renewable energy laboratory.

Manufactures and sells basic chemicals, acrylic products and functional chemicals

Suzhou Huizhen Medical Laboratory Co., Ltd., established on 2018-06-21, Business scope includes medical examination;Technology development in biomedical technology and related fields,technology transfer,technical consulting,Technical Services;Biochemical reagents and consumables,chemical agent,Research and development of instruments and accessories,Sales;software development,Sales and related technical services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physician's decision to manage a patient. Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.